One email a week. Catch up in five minutes.

The GammaRips weekly briefing — engine state, the latest Lab experiment, and what the pool's outcome data showed. No firehose, no FOMO.

We Use Cookies

We use cookies to enhance your experience, analyze site traffic, and for marketing purposes. By clicking "Accept," you agree to our use of cookies. Read our Privacy Policy.

NVAX

Name: NVAX overnight options flow scan record, 2026-10-12
Creator: GammaRips

BULL

2026-10-12

Overnight Scan Record · Healthcare

See the 2026-10-12 Morning Briefing

This is one row from the GammaRips nightly scan of about 3,500 optionable US stocks, tracked to its outcome. What membership means depends on the scan date. For scan dates from 2026-08-24, it is a liquidity rank: the 100 most liquid names, bullish only. For earlier scan dates, the scan selected on unusual options activity and included bearish names. The two sets are not one population. Data, not a recommendation. New here? See how the pool is built → Or put your AI agent on this data →

Score

6/10

Descriptive context. Not a quality rank and not a forecast.

Move

15.2%

Flow

$3.1M

Engine Flags(1 of 5 patterns matched. Descriptive, not a trade signal.)

Move Above 2x ATRThe session move was more than 2x the average true range.

AI Analysis

Model-written context on what the scan saw that night. It is context, not advice and not a trade instruction.

NVAX BULL $14C Oct 23 '26. The institutional options flow highlights a speculative, directional bet concentrating premium in out-of-the-money calls, capturing a strong sector-wide tailwind that has lifted major vaccine developers. Risk factor: Given the lack of a concrete company-specific catalyst and the stock's sensitivity to fleeting headlines, the momentum remains highly vulnerable to sudden reversals if the broader biotechnology sector bid cools.

Flow Breakdown

Call Volume

$2.8M

Put Volume

$295K

Flow Intent

DIRECTIONAL

Catalyst

Sector Rotation

More Bullish Flow · 2026-10-12

MRNA7/10 MRK7/10 IOVA6/10 IBRX6/10 PFE3/10 MDT2/10

Engine-Selected Contract

The contract the engine priced for this row. Descriptive, not a recommendation.

ContractO:NVAX261023C00014000

Strike$14.00

Expiration2026-10-23

Delta0.32

Key Levels

Resistance$13.38

Support$9.13

Price$12.75

SMA 50 / 200$10 / $9

52W Range$6 — $13

RSI (14)68

News & Catalyst Analysis

Key Headline

Novavax surged 14% and Moderna 11% with no company-specific catalyst identified, making both gains purely a sector-wide sentiment move

News Summary

Novavax shares have experienced heightened volatility and a recent double-digit recovery, tracking a broad sector-wide bid in biotechnology and vaccine developers. This upward momentum occurred without a fresh, company-specific fundamental catalyst, following previous wild swings triggered by headlines of a localized plague case in Russia. The massive call option volume suggests institutional flow is actively positioning to capture the highly volatile swings characteristic of this small-cap biotech name during sector rallies.

Flow Intent Analysis

The massive call volume concentrated at a strike above the current spot price, coupled with a highly sensitive biotech name riding a sector-wide bid, indicates speculative, anticipatory momentum positioning rather than reactive hedging.

One email a week. Catch up in five minutes.

The GammaRips weekly briefing — engine state, the latest Lab experiment, and what the pool's outcome data showed. No firehose, no FOMO.

Read the 2026-10-12 morning briefing for the full scan this NVAX row came from: the shape of the pool that day, the themes in the flow, and every other name in it.

How We Read This Flow

Plain-English explainers on the methodology behind signals like this one.

View all →

One email a week. Catch up in five minutes.

NVAX

Key Headline

News Summary

Flow Intent Analysis

One email a week. Catch up in five minutes.

How We Read This Flow

How to Analyze Options Flow

How to Read Options Volume vs Open Interest

How to Build an MCP Server for Options Trading